EGR1 and Alzheimer disease: In addition, our in vitro findings suggested that local E2 may exert a protective effect in AD brains by activating EGR1 accompanied with reduced soluble Aβ(1–42), and thereby maintaining synaptic and cognitive functions in early AD.